Vilanterol and Fluticasone Furoate

What is Vilanterol and Fluticasone Furoate?

Vilanterol and Fluticasone Furoate is a prescription medication combining two active ingredients: Vilanterol, a long-acting beta2-agonist (LABA), and Fluticasone Furoate, an inhaled corticosteroid (ICS). This combination is primarily used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is also approved for the maintenance treatment of asthma management in specific patient populations. Available in a dry powder inhaler device, this medication improves lung function and reduces the frequency of exacerbations. It is crucial to understand that Vilanterol and Fluticasone Furoate is not a rescue inhaler and should not be used for acute bronchospasm.

How Does it Work?

The efficacy of Vilanterol and Fluticasone Furoate stems from the synergistic action of its two components. Fluticasone Furoate is a potent inhaled corticosteroid that reduces airway inflammation. It suppresses the immune response, decreasing swelling and mucus production typical of asthma and COPD, thus preventing airway narrowing. Vilanterol is a selective long-acting beta2-agonist. It acts on beta2-adrenergic receptors in airway smooth muscles, leading to their relaxation and causing bronchodilation. This opens up air passages, allowing air to flow more freely. The long-acting nature of Vilanterol provides sustained bronchodilatory effect for approximately 24 hours, enabling once-daily dosing. By combining an ICS and a LABA, this medication addresses both the inflammatory and bronchoconstrictive aspects of chronic respiratory diseases, providing comprehensive symptom control.

Medical Uses

The primary medical indications for Vilanterol and Fluticasone Furoate are the long-term management of asthma and chronic obstructive pulmonary disease (COPD). For COPD patients, it improves lung function, reduces symptoms like breathlessness and coughing, and significantly decreases the rate of exacerbations. For asthma, it is indicated for maintenance treatment in patients where a combination product is appropriate, particularly when asthma is not adequately controlled with an ICS alone. It is vital to reiterate that this medication is a maintenance therapy and should not be used to relieve acute asthma attacks or sudden worsening of COPD symptoms. For such emergencies, a fast-acting rescue inhaler is necessary. Regular use as prescribed is key to achieving optimal benefits.

Dosage

The typical dosage of Vilanterol and Fluticasone Furoate is one inhalation once daily. Always follow your healthcare professional's specific instructions and the medication's leaflet. It is supplied in a dry powder inhaler, and proper technique is essential for effective delivery. Your doctor or pharmacist will demonstrate correct usage. Use the medication at the same time each day, as prescribed, and do not exceed the recommended dose. If a dose is missed, take it as soon as remembered, unless it's almost time for the next dose, then skip the missed dose. Never take a double dose. Consistent daily use is necessary for managing chronic respiratory conditions.

Side Effects

Like all medications, Vilanterol and Fluticasone Furoate can cause side effects. Common ones include headache, nasopharyngitis (cold symptoms), oral candidiasis (thrush), and upper respiratory tract infection. To minimize thrush, rinse your mouth with water and spit it out after each dose. More serious, though less common, side effects include pneumonia (especially in COPD patients), paradoxical bronchospasm (sudden worsening of breathing), cardiovascular effects (increased heart rate/blood pressure), and adrenal suppression. Seek immediate medical attention for severe chest pain, irregular heartbeat, sudden difficulty breathing, facial/throat swelling, or rash. Discuss any concerns with your doctor.

Drug Interactions

Vilanterol and Fluticasone Furoate can interact with certain other medications. Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin, grapefruit products) can increase systemic exposure to both components, raising the risk of corticosteroid side effects or cardiovascular effects from vilanterol. Co-administration with these inhibitors is generally not recommended. Concurrent use of other long-acting beta2-agonists (LABAs) should be avoided to prevent overdose. Beta-blockers, including ophthalmic ones, may block the pulmonary effect of vilanterol, potentially causing severe bronchospasm. Diuretics that are not potassium-sparing may also interact, leading to electrolyte imbalances. Always inform your healthcare provider about all medications and supplements you are taking.

FAQ

• Is Vilanterol and Fluticasone Furoate a rescue inhaler?

  No, it is a maintenance medication for long-term control of asthma and COPD. It should not be used for sudden breathing problems. Always carry a separate rescue inhaler for emergencies.

• How long does it take to start working?

  While some relief may be felt quickly, the full therapeutic benefits, especially anti-inflammatory effects, develop over several days to weeks of consistent daily use. Continue using as prescribed.

• Can children use Vilanterol and Fluticasone Furoate?

  Age indications vary by region and brand. It's approved for certain age groups in asthma and typically for adults in COPD. Always consult a pediatrician or healthcare provider.

Products containing Vilanterol and Fluticasone Furoate are available through trusted online pharmacies. You can browse Vilanterol and Fluticasone Furoate-based medications at ShipperVIP or Medicenter.

Summary

Vilanterol and Fluticasone Furoate is a crucial combination medication for individuals managing chronic respiratory conditions like asthma and COPD. By synergistically reducing inflammation and promoting bronchodilation, it offers comprehensive, once-daily control over symptoms, improves lung function, and helps prevent exacerbations. Adherence to prescribed dosage and proper inhaler technique are paramount. While generally well-tolerated, awareness of potential side effects and drug interactions is important. This medication is a cornerstone of long-term disease management, but it is not a substitute for a rescue inhaler during acute episodes. Open communication with your healthcare provider ensures safe and effective treatment.